Nikhil Lalwani

Nikhil Lalwani

Chief Executive Officer chez ANI PHARMACEUTICALS, INC.

Fortune : 27 M $ au 31/03/2024

46 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mr. Nikhil Lalwani is a President, Chief Executive Officer & Director at ANI Pharmaceuticals, Inc. He is on the Board of Directors at ANI Pharmaceuticals, Inc. Mr. Lalwani was previously employed as a Chief Executive Officer-India RX Business by Cipla Ltd., a Chief Executive Officer by Cipla USA, Inc., a Chief Executive Officer by InvaGen Pharmaceuticals, Inc., and an Associate Partner by McKinsey & Co., Inc. He received his undergraduate degree from Georgia Institute of Technology, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
23/03/2024 394 174 ( 1,87% ) 27 M $ 31/03/2024

Postes actifs de Nikhil Lalwani

SociétésPosteDébut
ANI PHARMACEUTICALS, INC. Chief Executive Officer 08/09/2020
Tous les postes actifs de Nikhil Lalwani

Anciens postes connus de Nikhil Lalwani

SociétésPosteFin
CIPLA LIMITED Corporate Officer/Principal 01/08/2020
Chief Executive Officer 01/04/2020
Chief Executive Officer 01/04/2020
Corporate Officer/Principal -
Voir l'expérience en détail de Nikhil Lalwani

Formation de Nikhil Lalwani

Georgia Institute of Technology Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Nikhil Lalwani

Relations

22

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ANI PHARMACEUTICALS, INC.

Health Technology

CIPLA LIMITED

Health Technology

Entreprise privées3

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Nikhil Lalwani